They utilized Toll-like receptor-5 deficient (TLR5KO) mice, which exhibit altered gut microbiota, to induce metabolic syndrome, and administered chronic antibiotics to TLR5KO mice to prevent metabolic syndrome (TLR5KOΔMicrobiota). Here, TLR5 is linked to metabolic syndrome.